Literature DB >> 6330303

Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process.

P J Whitehouse, D Lynch, M J Kuhar.   

Abstract

Studies of neurotransmitter and drug receptor alterations in neurodegenerative disorders have contributed to our understanding of the pathophysiology of these conditions. The effect of postmortem delay in freezing tissue after death and prolonged storage of tissue prior to analysis on receptor binding assays are potential artifacts that may limit interpretation of the effects of disease on receptor populations. We used a rat model of the human autopsy process to study the effects of increasing postmortem delay and storage time on N-methylscopolamine (NMS), p-aminoclonidine (PAC), flunitrazepam (FLU), and spiperone binding in a variety of rat brain regions. The rat brains were cooled using a temperature-controlled environment and thermistor probe to follow cooling curves obtained in human brain. Brains were cooled to either room temperature (22 degrees C) or refrigerator temperature (4 degrees C). For three of the four receptors, receptor binding decreased as postmortem delay before freezing increased, particularly in tissue cooled to room temperature. Unlike binding at other receptor sites, FLU binding increased with increasing postmortem delay to freezing. Different effects on KD and Bmax were noted for each ligand studied. No effects of the freezing process itself or storage at -80 degrees C were detectable.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330303     DOI: 10.1111/j.1471-4159.1984.tb00934.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  Immunohistochemistry of cholinergic receptors.

Authors:  H Schröder
Journal:  Anat Embryol (Berl)       Date:  1992-10

2.  Expression profile of Bag 1 in the postmortem brain.

Authors:  Christine Curcio; John J Asheld; Janet M Chabla; Diana Ayubcha; Brian H Hallas; Judith M Horowitz; German Torres
Journal:  J Chem Neuroanat       Date:  2006-10-13       Impact factor: 3.052

3.  Quantitative receptor autoradiography in the human brain. Methodical aspects.

Authors:  K Zilles; A Schleicher; M Rath; A Bauer
Journal:  Histochemistry       Date:  1988

4.  Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Toshio Ota; J Javier Meana; Luis F Callado; Isao Matsuoka; Jesús A García-Sevilla
Journal:  Purinergic Signal       Date:  2018-02-28       Impact factor: 3.765

5.  Characterization of [35S]t-butylbicyclophosphorothionate ([35S]TBPS) binding to GABAA receptors in postmortem human brain.

Authors:  J R Atack; Y Ohashi; R M McKernan
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

6.  Loss of muscarinic cholinergic receptors from the temporal cortex of alcohol abusers.

Authors:  G Freund; W E Ballinger
Journal:  Metab Brain Dis       Date:  1989-06       Impact factor: 3.584

7.  Dual-isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion.

Authors:  M S al-Tikriti; H M Dey; S S Zoghbi; R M Baldwin; Y Zea-Ponce; R B Innis
Journal:  Eur J Nucl Med       Date:  1994-03

8.  Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain.

Authors:  S W D'Souza; S E McConnell; P Slater; A J Barson
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

Review 9.  Peptide neuroregulators: the opioid system as a model.

Authors:  J D Barchas; C Evans; G R Elliott; P A Berger
Journal:  Yale J Biol Med       Date:  1985 Nov-Dec

10.  GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors.

Authors:  Luisa Rocha; Mario Alonso-Vanegas; Iris E Martínez-Juárez; Sandra Orozco-Suárez; David Escalante-Santiago; Iris Angélica Feria-Romero; Cecilia Zavala-Tecuapetla; José Miguel Cisneros-Franco; Ricardo Masao Buentello-García; Jesús Cienfuegos
Journal:  Front Cell Neurosci       Date:  2015-01-05       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.